Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$92.34
-1.47-1.57%
Last update: Oct 6, 7:59 PM
$92.35
-1.46-1.56%
Kodiak Sciences Inc (KOD) Stock Price, Quote, News & History
KODNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Kodiak Sciences Inc has developed a new technology platform, the Antibody Biopolymer Conjugate (ABC) platform, for retinal medicines. Its investigational medicine, tarcocimab tedromer (Zenkuda or tarcocimab), is an anti-VEGF therapy built on Kodiak's...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Kodiak Sciences (NASDAQ:KOD) through any online brokerage.
Other companies in Kodiak Sciences’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Kodiak Sciences has a consensus price target of $53.00.
The stock price for Kodiak Sciences (NASDAQ: KOD) is $92.35 last updated October 6, 2026 at 7:59 PM EDT.
There are no upcoming dividends for Kodiak Sciences.
Kodiak Sciences does not have any upcoming earnings scheduled.
There is no upcoming split for Kodiak Sciences.
Kodiak Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
